None
Quote | Oncocyte Corporation (NYSE:OCX)
Last: | $4.805 |
---|---|
Change Percent: | 4.57% |
Open: | $4.58 |
Close: | $4.805 |
High: | $5 |
Low: | $4.55 |
Volume: | 2,265,701 |
Last Trade Date Time: | 03/19/2021 04:10:44 am |
News | Oncocyte Corporation (NYSE:OCX)
IRVINE, Calif., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced that CEO Josh Riggs will be presenting a corporate overview at the upcoming Sequire Investor Summit 2024. The conference is scheduled for January 23-25, 2024 at t...
- Significant unmet need for regulated product in $2B US testing market - Opportunity for expedited pathway for kitted product in development IRVINE, Calif., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced it has...
Message Board Posts | Oncocyte Corporation (NYSE:OCX)
Subject | By | Source | When |
---|---|---|---|
$OCX short squeeze | MikeKato2002 | investorshub | 05/09/2023 11:03:57 PM |
what do you make of this data? | jdheart101 | investorshub | 05/09/2023 5:12:32 AM |
$OCX Price now last up | jdheart101 | investorshub | 05/08/2023 8:51:18 PM |
best news of the day | georgie18 | investorshub | 05/06/2023 11:37:40 PM |
$OCX Long and strong lets hope im right | pymadams | investorshub | 05/05/2023 10:37:03 PM |
News, Short Squeeze, Breakout and More Instantly...
IRVINE, Calif., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corporation (NASDAQ:OCX), a precision diagnostics company, today announced that CEO J...
IRVINE, Calif., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced that CEO Josh Riggs will be presenting a corporate overview at the upcoming Sequire Investor Summit 2024. The conference is scheduled for January 23-25, 2024 at t...
- Significant unmet need for regulated product in $2B US testing market - Opportunity for expedited pathway for kitted product in development IRVINE, Calif., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced it has...